Patent 9265737 was granted and assigned to Neos Therapeutics on February, 2016 by the United States Patent and Trademark Office.
The invention relates to a pharmaceutical composition comprising amphetamines complexed with ion-exchanged resin particles to form drug-resin particles. The composition provides for prolonged therapy.